Based on the first link page 24, my quick bottomline (sort of) guesstimate will be:
GMV's LTM (last 12 months) revenue as of 30/06/2020 is indicated as US$11m (the old whole 2019 yr is US$5mil). If leave July, August, Sept hospital revenues for the time being,
Apply x10 US$11m x 10 = US$110m Mktcap --> divided by 60m total shares = US$1.83 = approx A$0.14
Apply x20 (quite possible) US$11m x 20 = US$220 MktCap --> divided by 60m total shares = US$3.7 = approx A$0.28
Apply x25 US$11m x 25 = US$275 MktCap --> divided by 60m total shares = US$4.6 = approx A$0.36
...
If revenue is calculated based on 2020 calendar year (it will be > US$11m), then it is quite possible the target IPO price $5 - $7 might be achieved. imo.
- Forums
- ASX - By Stock
- GMV
- GMVD - NASDAQ IPO
GMVD - NASDAQ IPO, page-7
-
- There are more pages in this discussion • 1,925 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online